Ranibizumab and Risk of Hospitalisation for Ischaemic Stroke and Myocardial Infarction in Patients with Age-Related Macular Degeneration: A Self-Controlled Case-Series Analysis

BACKGROUND: Ranibizumab, a vascular endothelial growth factor (VEGF) inhibitor, is used in the treatment of age-related macular degeneration. Inhibition of VEGF has an anti-angiogenic action and is associated with thrombogenicity, thus, myocardial infarction and ischaemic stroke are potential side e...

Descripción completa

Detalles Bibliográficos
Autores principales: Pratt, Nicole L., Ramsay, Emmae N., Kemp, Anna, Kalisch-Ellett, Lisa M., Shakib, Sepehr, Caughey, Gillian E., Ryan, Philip, Graves, Stephen, Roughead, Elizabeth E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2014
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4242979/
https://www.ncbi.nlm.nih.gov/pubmed/25260802
http://dx.doi.org/10.1007/s40264-014-0231-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4242979/
https://www.ncbi.nlm.nih.gov/pubmed/25260802
http://dx.doi.org/10.1007/s40264-014-0231-2

Ejemplares similares